ARGENICA ORDINARY (AGN) News
Latest articles and price-sensitive announcements with AI sentiment classification.
ASXARG007 (Xaranetide) Completes All Three FDA Requested Assays
other announcement
Google NewsWhy Argenica Therapeutics (ASX:AGN) Shares Are Back in Focus Today? - Kalkine
Why Argenica Therapeutics (ASX:AGN) Shares Are Back in Focus Today? Kalkine
IND Application Advanced With Successful Completion of Assay
other announcement
Small CapsClinical Advisory Committee Established to Advance Phase 2b
other announcement
Quarterly Activities/Appendix 4C Cash Flow Report
other announcement
Presentations at European Stroke Organisation Conference
other announcement
Argenica Receives $3.97m R&D Tax Incentive Cash Rebate
other announcement
Investor Presentation - Euroz Hartleys Healthcare Conference
other announcement
Quarterly Activities/Appendix 4C Cash Flow Report
other announcement
AI Analysis Reveals Efficacy In Severe Stroke Patients
other announcement
Positive TNK Study Results Fulfil Key FDA Requirement
other announcement
ARG-007 Efficacious Dose Validated in New Preclinical Study
other announcement
Quarterly Activities/Appendix 4C Cash Flow Report
other announcement
Investor Presentation - Cannacord Dug & Device Conference
other announcement
Notification regarding unquoted securities - AGN
other announcement
Phase 2 Trial Promising Improvements in Functional Outcomes
other announcement
Date of AGM & Closing Date for Director Nominations
other announcement
Topline Phase 2 Trial Results of ARG-007 in AIS Patients
other announcement
Argenica Appoints Vice President of Regulatory Affairs
other announcement
Quarterly Activities/Appendix 4C Cash Flow Report
other announcement
Argenica to Progress Clinical Development in TBI
other announcement
Notification regarding unquoted securities - AGN
other announcement
Quarterly Activities/Appendix 4C Cash Flow Report
other announcement